First experimental Zika vaccine gets nod from FDA, moves to human trials

The US Food and Drug Administration on Monday approved the first human trial of an experimental Zika vaccine, according to a joint announcement by the two companies behind the new therapy.

The companies, Inovio Pharmaceuticals, Inc., based in Pennsylvania, and GeneOne Life Science, Inc., based in South Korea, said that their DNA-based vaccine candidate, dubbed GLS-5700, will be given to 40 people in a phase I trail. The trial will start “in the next weeks,” the companies said, and could yield results later this year.

Tags: 

Read more: First experimental Zika vaccine gets nod from FDA, moves to human trials

Story added 21. June 2016, content source with full text you can find at link above.